Graybug

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch Graybug and buy or sell other stocks, ETFs, and their options commission-free!

About GRAY

CalciMedica, Inc. operates as a clinical-stage biopharmaceutical company. It focuses on developing therapies for life-threatening inflammatory diseases. 

CEO
Rachel Anne Leheny, PhD
CEORachel Anne Leheny, PhD
Employees
14
Employees14
Headquarters
La Jolla, California
HeadquartersLa Jolla, California
Founded
2007
Founded2007
Employees
14
Employees14

GRAY Key Statistics

Market cap
78.41M
Market cap78.41M
Price-Earnings ratio
-2.01
Price-Earnings ratio-2.01
Dividend yield
Dividend yield
Average volume
23.56K
Average volume23.56K
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$4.26
52 Week high$4.26
52 Week low
$1.42
52 Week low$1.42

Stock Snapshot

As of today, Graybug(GRAY) shares are valued at $5.50. The company's market cap stands at 78.41M, with a P/E ratio of -2.01.

On 2026-03-10, Graybug(GRAY) shares started trading at —, with intraday highs of — and lows of —.

Trading activity shows a volume of 0, compared to an average daily volume of 23.56K.

The stock's 52-week range extends from a low of $1.42 to a high of $4.26.

The stock's 52-week range extends from a low of $1.42 to a high of $4.26.

People also own

Based on the portfolios of people who own GRAY. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.